HCS LipidTOX™ Phospholipidosis and Steatosis Detection Kit, for high-content screening, for cellular imaging
HCS LipidTOX™ Phospholipidosis and Steatosis Detection Kit, for high-content screening, for cellular imaging
Invitrogen™

HCS LipidTOX™ Phospholipidosis and Steatosis Detection Kit, for high-content screening, for cellular imaging

HCS LipidTOX™ Phospholipidosis and Steatosis Detection Kit offers a complete set of reagents for performing image-based high-content screening (HCS) assaysRead more
Have Questions?
Catalog NumberQuantity
H341581200 Assays
Catalog number H34158
Price (EUR)
946,00
Each
In stock
Add to cart
Quantity:
1200 Assays
Recurring order eligible. Learn more »
Price (EUR)
946,00
Each
Add to cart
Ask our AI about this Product
HCS LipidTOX™ Phospholipidosis and Steatosis Detection Kit offers a complete set of reagents for performing image-based high-content screening (HCS) assays to characterize phospolipidosis and steatosis, toxic side effects on lipid metabolism that can be triggered by drugs or other compounds. The kit supplies LipidTOX™ Red phospholipid stain and LipidTOX™ Green neutral lipid stain, which can be used sequentially for the analysis of phospholipidosis and steatosis, respectively, or can be used in isolation for single-parameter analysis. Both fluorescent probes can be easily detected with fluorescence microscopes and can be quantified with stand-alone image analysis software or the built-in image analysis software of most HCS readers. In addition to the phospholipid and neutral lipid stains, this kit supplies the nuclear stain Hoechst 33342, propranolol and cyclosporin A (control compounds), and DMSO. Sufficient reagents are supplied for 2, 96-well plates (H34157) or 10, 96-well plates (H34158).
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Detection MethodFluorescence
Dye TypeOther Label(s) or Dye(s)
Format96-well plate
Quantity1200 Assays
Shipping ConditionRoom Temperature
For Use With (Equipment)High Content Analysis Instrument
Product LineLipidTOX, Molecular Probes
Product TypePhospholipidosis and Steatosis Detection Kit
Unit SizeEach
Contents & Storage
When stored at -20°C, desiccated, and protected from light, the kit is stable for at least 6 months.
Have questions about this product? Ask our AI assisted search.
This is an AI-powered search and may not always get things right. You can help us make it better with a thumbs up or down on individual answers or by selecting the “Give feedback" button. Your search history and customer login information may be retained by Thermo Fisher and processed in accordance with our Privacy Notice.

Figures

Fluorescence spectra

Fluorescence spectra

Documents & Downloads

Certificates

Lot #Certificate TypeDateCatalog Number(s)
3203001Certificate of AnalysisMay 18, 2025H34158
3143073Certificate of AnalysisMay 12, 2025H34158
2983210Certificate of AnalysisNov 13, 2024H34158
2836735Certificate of AnalysisJul 19, 2024H34158
2770839Certificate of AnalysisFeb 06, 2024H34158
5 results displayed, search above for a specific certificate

Safety Data Sheets

Frequently asked questions (FAQs)

After thawing LipidTOX Red phospholipidosis detection reagent, some minute aggregates might be observed in the solution. They usually will disappear if the vial is incubated in a 37 degrees C water bath for 5 minutes. These aggregates do not affect the performance of the assay.
Any aggregates that remain after the stain is diluted in media are removed by 0.2 µm filtration before the labeling solution is added to the cells, as recommended in the protocol.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

Citations & References (4)

Citations & References
Abstract
Fluorescent high-content imaging allows the discrimination and quantitation of E-LDL-induced lipid droplets and Ox-LDL-generated phospholipidosis in human macrophages.
Authors:Grandl M, Schmitz G,
Journal:Cytometry A
PubMed ID:20014301
'Macrophage foam cells formed during uptake of atherogenic lipoproteins are a hallmark of atherosclerotic lesion development. In this study, human macrophages were incubated with two prototypic atherogenic LDL modifications enzymatically degraded LDL (E-LDL) and oxidized LDL (Ox-LDL) prepared from the same donor LDL. To detect differences in macrophage lipid storage, ... More
In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies.
Authors:Nioi P, Perry BK, Wang EJ, Gu YZ, Snyder RD
Journal:Toxicol Sci
PubMed ID:17567588
'Phospholipidosis (PLD) is characterized by the excessive intracellular accumulation of phospholipids. It is well established that a large number of cationic amphiphilic drugs have the potential to induce PLD. In the present study, we describe two facile in vitro methods to determine the PLD-inducing potential of a molecule. The first ... More
Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation.
Authors:
Journal:Cell Rep
PubMed ID:33238129
Increased Akt-Driven Glycolysis Is the Basis for the Higher Potency of CD137L-DCs.
Authors:
Journal:Front Immunol
PubMed ID:31068941
4 total citations

Other products to consider



Share catalog number, name or link

1x1 image pixel for data collection